"When the cancer treatment is worse than the disea
Post# of 72440
Quote:
But after a few months, he noted some mild pain in his feet. Soon, severe pain shot through his legs. His doctor explained that this “nerve pain” was a side effect from the therapy, preventing him from walking and once again making him bed-bound. This time, it wasn’t the disease that was debilitating him; it was the treatment.....
The Food and Drug Administration had approved the treatment based only on a small study of about 100 patients, one-third of whom demonstrated complete remission. Although side effects were rare, the average age of patients in the study was 31. This is typical of cancer-treatment studies, which most often test new drugs in younger and healthier people — not older people with lots of medical conditions. New cancer treatments often represent important scientific advances, but the actual impact on patients is almost always far from a slam-dunk. The absence of data oversimplifies complex new treatments as shiny black boxes. There appear to be no trade-offs to consider. The default for many patients looking for treatment is “yes” — cost be damned.
https://www.washingtonpost.com/opinions/when-...1b8afa3309
Also I'd like to point out that Kevetrin was tried on STAGE 4, TERMINAL cancer patients. So if anyone should have developed horrendous side effects like the patient in the article, it was them.
And they didn't.